138 related articles for article (PubMed ID: 35303523)
21. The clinicopathological significance of micropapillary pattern in colorectal cancers.
Pyo JS; Park MJ; Kang DW
Hum Pathol; 2018 Jul; 77():159-165. PubMed ID: 29634975
[TBL] [Abstract][Full Text] [Related]
22. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):613-21. PubMed ID: 23573307
[TBL] [Abstract][Full Text] [Related]
23. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of the chromosome 11 mucin genes in colorectal cancer.
Sylvester PA; Myerscough N; Warren BF; Carlstedt I; Corfield AP; Durdey P; Thomas MG
J Pathol; 2001 Oct; 195(3):327-35. PubMed ID: 11673830
[TBL] [Abstract][Full Text] [Related]
25. Early colorectal carcinomas: CD10 expression, mucin phenotype and submucosal invasion.
Hirano K; Nimura S; Mizoguchi M; Hamada Y; Yamashita Y; Iwasaki H
Pathol Int; 2012 Sep; 62(9):600-11. PubMed ID: 22924846
[TBL] [Abstract][Full Text] [Related]
26. Mucinous differentiation in colorectal cancer: molecular, histological and clinical aspects.
Debunne H; Ceelen W
Acta Chir Belg; 2013; 113(6):385-90. PubMed ID: 24494463
[TBL] [Abstract][Full Text] [Related]
27. REG IV overexpression in an early stage of colorectal carcinogenesis: an immunohistochemical study.
Li XH; Zheng Y; Zheng HC; Takahashi H; Yang XH; Masuda S; Takano Y
Histol Histopathol; 2010 Apr; 25(4):473-84. PubMed ID: 20183800
[TBL] [Abstract][Full Text] [Related]
28. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
[TBL] [Abstract][Full Text] [Related]
29. Phenotype analysis by MUC2, MUC5AC, MUC6, and CD10 expression in Epstein-Barr virus-associated gastric carcinoma.
Barua RR; Uozaki H; Chong JM; Ushiku T; Hino R; Chang MS; Nagai H; Fukayama M
J Gastroenterol; 2006 Aug; 41(8):733-9. PubMed ID: 16988760
[TBL] [Abstract][Full Text] [Related]
30. Gastric adenocarcinoma with enteroblastic differentiation should be differentiated from hepatoid adenocarcinoma: A study with emphasis on clear cells and clinicopathologic spectrum.
Kwon MJ; Byeon S; Kang SY; Kim KM
Pathol Res Pract; 2019 Sep; 215(9):152525. PubMed ID: 31301878
[TBL] [Abstract][Full Text] [Related]
31. Differentiation pathways in duodenal and ampullary carcinomas: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinomas.
Gürbüz Y; Klöppel G
Virchows Arch; 2004 Jun; 444(6):536-41. PubMed ID: 15071739
[TBL] [Abstract][Full Text] [Related]
32. Aberrant SOX2 expression in colorectal cancers does not correlate with mucinous differentiation and gastric mucin MUC5AC expression.
Raghoebir L; Biermann K; Kempen MB; Dubbink HJ; Dinjens WN; Hersmus R; Looijenga LH; Bruno MJ; Tibboel D; Rottier RJ; Smits R
Virchows Arch; 2014 Oct; 465(4):395-400. PubMed ID: 25108707
[TBL] [Abstract][Full Text] [Related]
33. MUC5AC/β-catenin expression and KRAS gene alteration in laterally spreading colorectal tumors.
Nakae K; Mitomi H; Saito T; Takahashi M; Morimoto T; Hidaka Y; Sakamoto N; Yao T; Watanabe S
World J Gastroenterol; 2012 Oct; 18(39):5551-9. PubMed ID: 23112547
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological and prognostic significance of mucin phenotype in gastric cancer.
Wakatsuki K; Yamada Y; Narikiyo M; Ueno M; Takayama T; Tamaki H; Miki K; Matsumoto S; Enomoto K; Yokotani T; Nakajima Y
J Surg Oncol; 2008 Aug; 98(2):124-9. PubMed ID: 18521835
[TBL] [Abstract][Full Text] [Related]
35. The prognostic significance of the mucin phenotype of gastric adenocarcinoma and its relationship with histologic classifications.
Lee OJ; Kim HJ; Kim JR; Watanabe H
Oncol Rep; 2009 Feb; 21(2):387-93. PubMed ID: 19148512
[TBL] [Abstract][Full Text] [Related]
36. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.
Ikarashi S; Nishikura K; Ajioka Y; Aoyagi Y
Gastric Cancer; 2013 Apr; 16(2):208-19. PubMed ID: 22829163
[TBL] [Abstract][Full Text] [Related]
37. Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype.
Kumashiro Y; Yao T; Aishima S; Hirahashi M; Nishiyama K; Yamada T; Takayanagi R; Tsuneyoshi M
Hum Pathol; 2007 Jun; 38(6):857-63. PubMed ID: 17320150
[TBL] [Abstract][Full Text] [Related]
38. Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?
Khor TS; Alfaro EE; Ooi EM; Li Y; Srivastava A; Fujita H; Park Y; Kumarasinghe MP; Lauwers GY
Am J Surg Pathol; 2012 Mar; 36(3):331-42. PubMed ID: 22261707
[TBL] [Abstract][Full Text] [Related]
39. Alterations in mucin expression in ovarian mucinous tumors: immunohistochemical analysis of MUC2, MUC5AC, MUC6, and CD10 expression.
Hirabayashi K; Yasuda M; Kajiwara H; Itoh J; Miyazawa M; Hirasawa T; Muramatsu T; Murakami M; Mikami M; Osamura RY
Acta Histochem Cytochem; 2008 Apr; 41(2):15-21. PubMed ID: 18493590
[TBL] [Abstract][Full Text] [Related]
40. Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background.
Tajima Y; Yamazaki K; Makino R; Nishino N; Aoki S; Kato M; Morohara K; Kaetsu T; Kusano M
Clin Cancer Res; 2006 Nov; 12(21):6469-79. PubMed ID: 17085661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
